QUANTITATIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC, GAS-CHROMATOGRAPHIC, AND GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ANALYSIS OF TICLOPIDINE IN BABOON PLASMA AFTER SOLID-PHASE EXTRACTION

被引:20
作者
ARNOUX, P [1 ]
SALES, Y [1 ]
MANDRAY, M [1 ]
LECHAT, P [1 ]
BERGER, Y [1 ]
CANO, JP [1 ]
机构
[1] SANOFI RECH, DEPT METAB & PHARMACOKINET, F-34184 MONTPELLIER 04, FRANCE
关键词
D O I
10.1002/jps.2600801119
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High-performance liquid chromatography with UV detection (HPLC-UV) and gas chromatography with either nitrogen phosphorus (GC-NPD) or mass spectrometry (GC-MS) detection were used for the determination of ticlopidine in plasma. Solid-phase extraction of ticlopidine from plasma was performed using Extrelut columns without pH adjustment, and using hexane as the solvent of elution. With HPLC, a mobile phase of 0.01 M pH 7.8 phosphate buffer:acetonitrile (70:30) was passed through a mu-Bondapack C-18 column at a rate of 1.3 mL/min. Ultraviolet detection at 235 nm was sensitive to plasma ticlopidine concentrations of 0.05-mu-g/mL. The GC-NPD and GC-MS were performed on a DB-17 fused-silica column using on-column injection. For GC-NPD and GC-MS, limits of quantification were found to be 0.020 and 0.005-mu-g/mL, respectively. Compared with HPLC-UV, the GC methods were found to be more reproducible, sensitive, and specific and therefore more suitable for pharmacokinetic applications.
引用
收藏
页码:1092 / 1095
页数:4
相关论文
共 11 条
[1]  
ASHIDA SI, 1979, THROMB HAEMOSTASIS, V41, P436
[2]  
BRUNO JJ, 1983, THROMB RES, P59
[3]  
BRUNO JJ, 1983, TICLOPIDINE NEW DRUG, P295
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF TICLOPIDINE IN HUMAN-SERUM [J].
FUJIMAKI, Y ;
TSUMURA, M ;
TACHIZAWA, H .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1986, 106 (12) :1143-1145
[5]   THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE [J].
GENT, M ;
EASTON, JD ;
HACHINSKI, VC ;
PANAK, E ;
SICURELLA, J ;
BLAKELY, JA ;
ELLIS, DJ ;
HARBISON, JW ;
ROBERTS, RS ;
TURPIE, AGG .
LANCET, 1989, 1 (8649) :1215-1220
[6]   A RANDOMIZED TRIAL COMPARING TICLOPIDINE HYDROCHLORIDE WITH ASPIRIN FOR THE PREVENTION OF STROKE IN HIGH-RISK PATIENTS [J].
HASS, WK ;
EASTON, JD ;
ADAMS, HP ;
PRYSEPHILLIPS, W ;
MOLONY, BA ;
ANDERSON, S ;
KAMM, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) :501-507
[7]  
ITOH S, 1987, CHEM PHARM BULL, V35, P1304
[8]   PREVENTION OF MYOCARDIAL-INFARCTION AND STROKE IN PATIENTS WITH INTERMITTENT CLAUDICATION - EFFECTS OF TICLOPIDINE - RESULTS FROM STIMS, THE SWEDISH-TICLOPIDINE-MULTICENTER-STUDY [J].
JANZON, L ;
BERGQVIST, D ;
BOBERG, J ;
BOBERG, M ;
ERIKSSON, I ;
LINDGARDE, F ;
PERSSON, G .
JOURNAL OF INTERNAL MEDICINE, 1990, 227 (05) :301-308
[9]  
PANAK E, 1983, HAEMOSTASIS, V13, P1
[10]   TICLOPIDINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PLATELET-DEPENDENT DISEASE STATES [J].
SALTIEL, E ;
WARD, A .
DRUGS, 1987, 34 (02) :222-262